Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19

被引:0
作者
Matthijs P. Raadsen
Arvind Gharbharan
Carlijn C. E. Jordans
Anna Z. Mykytyn
Mart M. Lamers
Petra B. van den Doel
Henrik Endeman
Johannes P. C. van den Akker
Corine H. GeurtsvanKessel
Marion P. G. Koopmans
Casper Rokx
Marco Goeijenbier
Eric C. M. van Gorp
Bart J. A. Rijnders
Bart L. Haagmans
机构
[1] Erasmus MC,Viroscience Department
[2] Erasmus MC,Department of Medical Microbiology and Infectious Diseases
[3] Erasmus MC,Intensive Care Department
来源
Journal of Clinical Immunology | 2022年 / 42卷
关键词
COVID-19; SARS-CoV-2; Interferon alpha; Auto-antibodies; Convalescent plasma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:232 / 239
页数:7
相关论文
共 50 条
  • [31] CONVALESCENT PLASMA THERAPY: A PROMISING APPROACH IN THE TREATMENT OF COVID-19
    Ahire, Eknath D.
    Sonawane, Vijayraj N.
    Surana, Khemchand R.
    Jadhav, Khanderao R.
    Sonawane, Deepak D.
    Shah, Ayaz A.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (09): : 4078 - 4086
  • [32] Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection
    Kumar, Neil R.
    Karanam, Veena C.
    Kumar, Shari
    Kumar, Sunil D.
    [J]. SOUTHERN MEDICAL JOURNAL, 2023, 116 (05) : 427 - 433
  • [33] Convalescent plasma therapy for patients with severe COVID-19: A case series study
    Huang, Jinbao
    Weng, Heng
    Lan, Changqing
    Li, Hongyan
    [J]. MEDICINE, 2022, 101 (31)
  • [34] Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy
    Nashaat, Hebat-Allah Hassan
    Anani, Maha
    Attia, Fadia M.
    [J]. BLOOD RESEARCH, 2022, 57 (01) : 6 - 12
  • [35] COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
    Pirofski, Liise-anne
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (02) : 130 - 132
  • [36] COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?
    Rnjak, D.
    Ravlic, S.
    Sola, A-M
    Halassy, B.
    Semnicki, J.
    Superba, M.
    Hecimovic, A.
    Kurolt, I-C
    Kurtovic, T.
    Safranko, Z. Macak
    Polancec, D.
    Bendelja, K.
    Muslin, T.
    Jukic, I
    Vuk, T.
    Zenic, L.
    Artukovic, M.
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (03) : 264 - 270
  • [37] COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
    Askenase, Philip W.
    [J]. JOURNAL OF EXTRACELLULAR VESICLES, 2020, 10 (01)
  • [38] COVID-19 convalescent plasma composition and immunological effects in severe patients
    Acosta-Ampudia, Yeny
    Monsalve, Diana M.
    Rojas, Manuel
    Rodriguez, Yhojan
    Esteban Gallo, Juan
    Carlos Salazar-Uribe, Juan
    Jose Santander, Maria
    Cala, Monica P.
    Zapata, Wildeman
    Isabel Zapata, Maria
    Manrique, Ruben
    Mauricio Pardo-Oviedo, Juan
    Camacho, Bernardo
    Ramirez-Santana, Carolina
    Anaya, Juan-Manuel
    [J]. JOURNAL OF AUTOIMMUNITY, 2021, 118
  • [39] Convalescent plasma in Covid-19: Possible mechanisms of action
    Rojas, Manuel
    Rodriguez, Yhojan
    Monsalve, Diana M.
    Acosta-Ampudia, Yeny
    Camacho, Bernardo
    Esteban Gallo, Juan
    Rojas-Villarraga, Adriana
    Ramirez-Santana, Carolina
    Diaz-Coronado, Juan C.
    Manrique, Ruben
    Mantilla, Ruben D.
    Shoenfeld, Yehuda
    Anaya, Juan-Manuel
    [J]. AUTOIMMUNITY REVIEWS, 2020, 19 (07)
  • [40] Absence of pathogenic viruses in COVID-19 convalescent plasma
    Kandathil, Abraham J.
    Benner, Sarah E.
    Bloch, Evan M.
    Shrestha, Ruchee
    Ajayi, Olivia
    Zhu, Xianming
    Caturegli, Patrizio P.
    Shoham, Shmuel
    Sullivan, David
    Gebo, Kelly
    Quinn, Thomas C.
    Casadevall, Arturo
    Hanley, Daniel
    Pekosz, Andrew
    Redd, Andrew D.
    Balagopal, Ashwin
    Tobian, Aaron A. R.
    [J]. TRANSFUSION, 2023, 63 (01) : 23 - 29